21390260|t|Neurite outgrowth mediated by translation elongation factor eEF1A1: a target for antiplatelet agent cilostazol.
21390260|a|Cilostazol, a type-3 phosphodiesterase (PDE3) inhibitor, has become widely used as an antiplatelet drug worldwide. A recent second Cilostazol Stroke Prevention Study demonstrated that cilostazol is superior to aspirin for prevention of stroke after an ischemic stroke. However, its precise mechanisms of action remain to be determined. Here, we report that cilostazol, but not the PDE3 inhibitors cilostamide and milrinone, significantly potentiated nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells. Furthermore, specific inhibitors for the endoplasmic reticulum protein inositol 1,4,5-triphosphate (IP(3)) receptors and several common signaling pathways (PLC-gamma, PI3K, Akt, p38 MAPK, and c-Jun N-terminal kinase (JNK), and the Ras/Raf/ERK/MAPK) significantly blocked the potentiation of NGF-induced neurite outgrowth by cilostazol. Using a proteomics analysis, we identified that levels of eukaryotic translation elongation factor eEF1A1 protein were significantly increased by treatment with cilostazol, but not cilostamide, in PC12 cells. Moreover, the potentiating effects of cilostazol on NGF-induced neurite outgrowth were significantly antagonized by treatment with eEF1A1 RNAi, but not the negative control of eEF1A1. These findings suggest that eEF1A1 and several common cellular signaling pathways might play a role in the mechanism of cilostazol-induced neurite outgrowth. Therefore, agents that can increase the eEF1A1 protein may have therapeutic relevance in diverse conditions with altered neurite outgrowth.
21390260	60	66	eEF1A1	Gene	171361
21390260	100	110	cilostazol	Chemical	MESH:D000077407
21390260	112	122	Cilostazol	Chemical	MESH:D000077407
21390260	152	156	PDE3	Gene	498900
21390260	243	253	Cilostazol	Chemical	MESH:D000077407
21390260	254	260	Stroke	Disease	MESH:D020521
21390260	296	306	cilostazol	Chemical	MESH:D000077407
21390260	322	329	aspirin	Chemical	MESH:D001241
21390260	348	354	stroke	Disease	MESH:D020521
21390260	364	379	ischemic stroke	Disease	MESH:D002544
21390260	469	479	cilostazol	Chemical	MESH:D000077407
21390260	493	497	PDE3	Gene	498900
21390260	509	520	cilostamide	Chemical	MESH:C021294
21390260	525	534	milrinone	Chemical	MESH:D020105
21390260	562	581	nerve growth factor	Gene	310738
21390260	583	586	NGF	Gene	310738
21390260	617	621	PC12	CellLine	CVCL:0481
21390260	802	805	Akt	Gene	24185
21390260	821	844	c-Jun N-terminal kinase	Gene	116554
21390260	846	849	JNK	Gene	116554
21390260	868	871	ERK	Gene	24338
21390260	920	923	NGF	Gene	310738
21390260	953	963	cilostazol	Chemical	MESH:D000077407
21390260	1064	1070	eEF1A1	Gene	171361
21390260	1126	1136	cilostazol	Chemical	MESH:D000077407
21390260	1146	1157	cilostamide	Chemical	MESH:C021294
21390260	1162	1166	PC12	CellLine	CVCL:0481
21390260	1212	1222	cilostazol	Chemical	MESH:D000077407
21390260	1226	1229	NGF	Gene	310738
21390260	1305	1311	eEF1A1	Gene	171361
21390260	1350	1356	eEF1A1	Gene	171361
21390260	1386	1392	eEF1A1	Gene	171361
21390260	1478	1488	cilostazol	Chemical	MESH:D000077407
21390260	1556	1562	eEF1A1	Gene	171361
21390260	Negative_Correlation	MESH:D001241	MESH:D020521
21390260	Positive_Correlation	MESH:D000077407	171361
21390260	Negative_Correlation	MESH:D020105	498900
21390260	Negative_Correlation	MESH:D001241	MESH:D002544
21390260	Positive_Correlation	MESH:D000077407	310738
21390260	Negative_Correlation	MESH:D000077407	MESH:D020521
21390260	Association	171361	310738
21390260	Negative_Correlation	MESH:D000077407	MESH:D002544
21390260	Negative_Correlation	MESH:D000077407	498900
21390260	Association	MESH:D000077407	116554
21390260	Comparison	MESH:D000077407	MESH:D001241

